NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

Active Not RecruitingN/A

Sponsor: Methodist Health System

Conditions: Frailty, Sarcopenia, COVID-19

Interventions: COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC

Countries: United States

Frailty is associated with higher rates of morbidity, mortality, and failure to rescue after major surgical procedures. Sarcopenia is degenerative loss of skeletal muscle mass and strength. It is a key component of physical frailty and is associated with poorer post-surgical outcomes due to decreased patient strength and vitality.

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Age 18 years and older Underwent pre-transplant frailty assessment (PFA) at MDMC

Exclusion Criteria:

* Not a patient at Liver Institute at Methodist Dallas

Locations (1)

Dallas, Texas, United States